NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Prepare for the NAPLEX with our engaging exam simulation. Our quiz-style format offers multiple-choice questions, hints, and detailed explanations to enhance your learning experience. Get ready to ace your NAPLEX exam!

Practice this question and more.


In which patient population is Flibanserin (Addyi) indicated?

  1. Premenopausal females only

  2. Postmenopausal females

  3. All adults regardless of sex

  4. Adolescents

The correct answer is: Premenopausal females only

Flibanserin (Addyi) is indicated in premenopausal females only. It is specifically approved by the FDA for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women. HSDD is characterized by a lack of sexual desire that causes distress or interpersonal difficulty. Flibanserin works by affecting neurotransmitters in the brain to help increase sexual desire. This medication is not indicated for postmenopausal females, all adults regardless of sex, or adolescents, as its safety and efficacy have not been established in these populations.